{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T13:21:12Z","timestamp":1770038472712,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,17]]},"DOI":"10.7759\/cureus.40552","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T08:41:50Z","timestamp":1686991310000},"source":"Crossref","is-referenced-by-count":2,"title":["Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins"],"prefix":"10.7759","author":[{"given":"Tooba","family":"Salar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massiel","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Ocon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen JD","year":"2012","unstructured":"Cohen JD, Brinton EA, Ito MK, Jacobson TA. Understanding statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012, 6:208-15.","journal-title":"J Clin Lipidol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study","volume":"19","author":"Bruckert E","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, B\u00e9gaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther. 2005, 19:403-14. 10.1007\/s10557-005-5686-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25567","article-title":"Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child","volume":"56","author":"Mohassel P","year":"2017","unstructured":"Mohassel P, Foley AR, Donkervoort S, Fequiere PR, Pak K, B\u00f6nnemann CG, Mammen AL. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child. Muscle Nerve. 2017, 56:1177-81. 10.1002\/mus.25567","journal-title":"Muscle Nerve"},{"key":"ref4","unstructured":"Statin muscle-related adverse events. https.\/\/www.uptodate.com\/contents\/statin-muscle-related-adverse-events."},{"key":"ref5","article-title":"224th ENMC international workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach Y","year":"2018","unstructured":"Allenbach Y, Mammen A, Benveniste O, Stenzel W. 224th ENMC international workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord. 2018, 28:87-99.","journal-title":"Neuromuscul Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach Y","year":"2016","unstructured":"Allenbach Y, Keraen J, Bouvier AM, et al.. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016, 139:2131-5. 10.1093\/brain\/aww054","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003006","article-title":"HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma","volume":"87","author":"Tsujikawa K","year":"2016","unstructured":"Tsujikawa K, Hara K, Muro Y, et al.. HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology. 2016, 87:841-3. 10.1212\/WNL.0000000000003006","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000290","article-title":"Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy","volume":"3","author":"Kadoya M","year":"2016","unstructured":"Kadoya M, Hida A, Hashimoto Maeda M, et al.. Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol Neuroinflamm. 2016, 3:e290. 10.1212\/NXI.0000000000000290","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24541","article-title":"Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy","volume":"52","author":"Limaye V","year":"2015","unstructured":"Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve. 2015, 52:196-203. 10.1002\/mus.24541","journal-title":"Muscle Nerve"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew470","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou E","year":"2017","unstructured":"Tiniakou E, Pinal-Fernandez I, Lloyd TE, et al.. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017, 56:787-94. 10.1093\/rheumatology\/kew470","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen AL","year":"2015","unstructured":"Mammen AL, Tiniakou E. Intravenous immune globulin for statin-triggered autoimmune myopathy. N Engl J Med. 2015, 373:1680-2. 10.1056\/NEJMc1506163","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR myopathy","volume":"5","author":"Mohassel P","year":"2018","unstructured":"Mohassel P, Mammen AL. Anti-HMGCR myopathy. J Neuromuscul Dis. 2018, 5:11-20. 10.3233\/JND-170282","journal-title":"J Neuromuscul Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142315-chronic-anti-hmg-coa-reductase-positive-necrotizing-myositis-with-remote-exposure-to-statins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:24Z","timestamp":1707509004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142315-chronic-anti-hmg-coa-reductase-positive-necrotizing-myositis-with-remote-exposure-to-statins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.40552","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,17]]}}}